In Vitro Skin Retention of Crisaborole after Topical Application

Crisaborole, a nonsteroidal phosphodiesterase 4 inhibitor, represents the first nonsteroidal medication approved for the treatment of atopic dermatitis in over a decade. In this work, crisaborole skin permeation and retention was studied in vitro from a 2% ointment using porcine skin as barrier. Cri...

Descripción completa

Detalles Bibliográficos
Autores principales: Fantini, Adriana, Demurtas, Anna, Nicoli, Sara, Padula, Cristina, Pescina, Silvia, Santi, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355453/
https://www.ncbi.nlm.nih.gov/pubmed/32481663
http://dx.doi.org/10.3390/pharmaceutics12060491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355453/
https://www.ncbi.nlm.nih.gov/pubmed/32481663
http://dx.doi.org/10.3390/pharmaceutics12060491

Ejemplares similares